The understanding of the natural history of multiple sclerosis has many imp
lications for the design and interpretation of randomized controlled trials
. Selection criteria, patient stratification, outcome measurements, and def
initions of treatment failure can influence randomized controlled trial res
ults and limit comparisons among trials. The focus of future studies should
shift from short-term determinations of efficacy to definitive evaluations
of long-term effectiveness. This will require novel investigative strategi
es such as the use of historic controls derived from natural history studie
s. (C) 1999 Lippincott Williams & Wilkins.